Article info
PostScript
Letter
Prospective study of cancer survival in patients with HuD-antibody-associated paraneoplastic neurological disorders
- Correspondence to Dr Paul Maddison, Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, Nottingham, UK; paul.maddison{at}nhs.net
Citation
Prospective study of cancer survival in patients with HuD-antibody-associated paraneoplastic neurological disorders
Publication history
- Received January 11, 2021
- Revised February 17, 2021
- Accepted March 8, 2021
- First published March 30, 2021.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.